Gene Therapy Biotechnology Company
9804 Medical Center Dr. Fourth Floor Rockville MD 20850, Rockville, MD · PATRICK CHRISTMAS
| Year | Client | Period | Income | Expenses | Doc |
|---|---|---|---|---|---|
| 2023 | REGENXBIO |
4th Quarter (Oct 1 - Dec 31) 4th Quarter - Termination |
— | $91,000 | |
| 2023 | REGENXBIO |
3rd Quarter (July 1 - Sep 30) 3rd Quarter - Report |
— | $94,000 | |
| 2023 | REGENXBIO |
2nd Quarter (Apr 1 - June 30) 2nd Quarter - Report |
— | $90,000 | |
| 2023 | REGENXBIO |
1st Quarter (Jan 1 - Mar 31) 1st Quarter - Report |
— | $163,000 | |
| 2022 | REGENXBIO |
4th Quarter (Oct 1 - Dec 31) 4th Quarter - Report |
— | $70,000 | |
| 2022 | REGENXBIO |
3rd Quarter (July 1 - Sep 30) 3rd Quarter - Report |
— | $70,000 | |
| 2022 | REGENXBIO |
2nd Quarter (Apr 1 - June 30) 2nd Quarter - Report |
— | $82,000 | |
| 2022 | REGENXBIO |
1st Quarter (Jan 1 - Mar 31) 1st Quarter - Report |
— | $150,000 | |
| 2021 | REGENXBIO |
4th Quarter (Oct 1 - Dec 31) 4th Quarter - Report |
— | $60,000 | |
| 2021 | REGENXBIO |
3rd Quarter (July 1 - Sep 30) AMENDED |
— | $75,000 |
| Client | Filings | Total Income |
|---|---|---|
| REGENXBIO | 24 | — |
| Name | Disclosed Prior Position |
|---|---|
| BRUCE ARTIM | Senate Judiciary Committee Staff Member 1995-2006; (Chief Counsel and Staff Director 2003-04); Intellectual Property Su… |